Acetazolamide to extend the golden hour

The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. was awarded a $277,569 cooperative agreement from the Department of Defense Uniformed Services University of the Health Sciences to develop and test acetazolamide as a treatment to extend the golden hour for trauma patients.

Under the Uniformed Services University Medical Research Projects program (CFDA 12.750), the Foundation will conduct research from November 1, 2022 to April 30, 2025 to evaluate whether administering acetazolamide in pre-hospital and emergency department settings can delay the onset of ischemia in severely injured patients, allowing more time for their definitive care and improving outcomes. The Uniformed Services University's mission includes supporting the Military and Public Health Systems through medical research, and this award advances that goal by exploring strategies to optimize trauma care for service members and the general public.